Skip to content

Robotic assisted percutaneous nephrolithotomy study

Evaluation of robotic assisted fluoroscopic guided percutaneous nephrolithotomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs042190074
Enrollment
60
Registered
2019-10-21
Start date
2020-01-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urolithiasis renal stone

Interventions

RAF group (30 cases): Performing renal puncuture by ANT-X assisted fluoroscopic guidance during percutaneous nephrolithotomy. US group (30 cases): Performing renal puncuture by ultrasound guidance dur
percutaneous nephrolithotomy
nephrolithotomy, robot assist, fluoroscopic guidance, ultrasound guidance, renal puncture

Sponsors

Taguchi Kazumi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients whose age are between 16 and 80 years old, diagnosed with renal and/or upper ureteral stone at Nagoya City University Hospital, and planned for percutaneous nephrolithotomy 2) Stones for 15mm and larger in size 3) Patients who were obtained written informed consent - obtained written informed consent from themselves if they are 20 years old and older - obtained written informed consent from themselves and representatives if their age are between 16 and 19 years old

Exclusion criteria

Exclusion criteria: A) women with pregnant or its possibility B) having active pyelonephritis C) under anti-platelet/coagulation therapy within 1 week prior surgery D) difficult status for general/lumber anesthesia judged by anesthesiologist E) Best supportive care due to terminal carcinoma

Design outcomes

Primary

MeasureTime frame
1.success rate of inserting puncture needle from skin to anaimed renal calyx 2.success rate of nephrostomy access for renal collecting system with nephroscope

Secondary

MeasureTime frame
renal puncture time, fluoroscopic time, total operation time, perioperational complicationrate (hemorrhage needed transfusion, pulmonary embolism, fever more than 38 c degree, SIRS, ureteral injury, other organ injury), length of hospitalization

Contacts

Public ContactKazumi Taguchi

Nagoya City University Hospital

ktaguchi@med.nagoya-cu.ac.jp+81-52-853-8266

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026